TY - CHAP M1 - Book, Section TI - Special Considerations: ST-Segment Elevation Myocardial Infarction A1 - Sharma, Rahul A1 - Brodie, Bruce R. A1 - Henry, Timothy D. A2 - Samady, Habib A2 - Fearon, William F. A2 - Yeung, Alan C. A2 - King III, Spencer B. PY - 2017 T2 - Interventional Cardiology, 2e AB - ST-segment elevation myocardial infarction (STEMI) composes approximately 25% to 40% of myocardial infarction (MI) presentations. There has been remarkable progress in the treatment and clinical outcomes in STEMI patients over the past 2 decades. Where available within a reasonable time period, reperfusion with percutaneous coronary intervention (PCI) has been accepted as the preferred reperfusion strategy for STEMI (Fig. 37-1). As the number of patients receiving primary PCI has increased, mortality has declined (Fig. 37-2). In-hospital and 1-year mortality rates are currently 4% to 6% and 7% to 18%, respectively.1-4 Few other interventions in clinical medicine require the complex organization of health care delivery systems and the high level of technical expertise to achieve optimum outcomes. In this chapter, we review the evidence for PCI in STEMI, including management of patients presenting to non–PCI-capable centers as well as selected technical aspects of PCI including adjunctive pharmacotherapy. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesscardiology.mhmedical.com/content.aspx?aid=1146599514 ER -